Jaroslav Jenčo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jaroslav Jenčo has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Lucie Cahlíková
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
5 shared publications Eliška Kohelová
Charles Univ Prague, Dept Pharmacognosy & Pharmaceut Bot, Hradec Kralove 50003, Czech Republic
2 shared publications- Jan Korabecny
Department of Toxicology and Military Pharmacy Military Faculty of Medicine University of Defence in Brno Trebesska 1575 500 02 Hradec Kralove Czech Republic
2 shared publications - Jana Maříková
ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
2 shared publications - Jiří Kuneš
Department of Organic and Bioorganic Chemistry, Charles University, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
2 shared publications - Lenka Kujovská Krčmová
Department of Clinical Biochemistry and Diagnostics , University Hospital Hradec Králové , Hradec Králové , Czech Republic
2 shared publications
Latest Publications
- 11 November 2026
- Published by Springer Nature in Medicinal Chemistry Research
- p. 1-46
New diterpenoids from Croton L. species (2019–2025): structural diversity and bioactivity
- 11 November 2026
- Published by Springer Nature in Medicinal Chemistry Research
- p. 1-46
New diterpenoids from Croton L. species (2019–2025): structural diversity and bioactivity
- Open Access
- 4 September 2024
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 87 (9) , 2317-2326
Undescribed Amaryllidaceae Alkaloids from Zephyranthes citrina and Their Cytotoxicity
This phytochemical study presents the isolation of eight alkaloids from Zephyranthes citrina Baker. The structures of the new alkaloids, zephycitrine (1) and 6-oxonarcissidine (2), were established by analysis of spectroscopic and spectrometric data. Processing the EtOH extract under acid-base conditions yielded the unreported isolation artifacts 3 and 4. This work also provides analytical data for alkaloids not properly described in the literature (5 and 6). The hippeastidine/zephyranine scaffolds in derivatives 3, 4, and 8-10 are also thoroughly discussed. Furthermore, a cytotoxicity screening of 25 Amaryllidaceae alkaloids isolated from Z. citrina was performed. Only the known alkaloids haemanthamine (12), haemanthidine (13), and lycorine (27) showed significant cell growth inhibition.
- 4 September 2024
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 87 (9) , 2317-2326
Open AccessUndescribed Amaryllidaceae Alkaloids from Zephyranthes citrina and Their Cytotoxicity
This phytochemical study presents the isolation of eight alkaloids from Zephyranthes citrina Baker. The structures of the new alkaloids, zephycitrine (1) and 6-oxonarcissidine (2), were established by analysis of spectroscopic and spectrometric data. Processing the EtOH extract under acid-base conditions yielded the unreported isolation artifacts 3 and 4. This work also provides analytical data for alkaloids not properly described in the literature (5 and 6). The hippeastidine/zephyranine scaffolds in derivatives 3, 4, and 8-10 are also thoroughly discussed. Furthermore, a cytotoxicity screening of 25 Amaryllidaceae alkaloids isolated from Z. citrina was performed. Only the known alkaloids haemanthamine (12), haemanthidine (13), and lycorine (27) showed significant cell growth inhibition.
- Open Access
- 22 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (5) , 1601-1625
Carltonine-derived compounds for targeted butyrylcholinesterase inhibition
Innovative chemotype design provided 41 novel hBChE inhibitors. CNS availability was predicted using the BBB score. Potent derivatives showed favorable drug-like properties and acceptable safety profiles in SH-SY5Y and HepG2 cells.
- 22 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (5) , 1601-1625
Open AccessCarltonine-derived compounds for targeted butyrylcholinesterase inhibition
Innovative chemotype design provided 41 novel hBChE inhibitors. CNS availability was predicted using the BBB score. Potent derivatives showed favorable drug-like properties and acceptable safety profiles in SH-SY5Y and HepG2 cells.
- Open Access
Amaryllidaceae Alkaloids of Different Structural Types from Narcissus L. cv. Professor Einstein and Their Cytotoxic Activity
In this detailed phytochemical study of Narcissus cv. Professor Einstein, we isolated 23 previously known Amaryllidaceae alkaloids (1–23) of several structural types and one previously undescribed alkaloid, 7-oxonorpluviine. The chemical structures were identified by various spectroscopic methods (GC-MS, LC-MS, 1D, and 2D NMR spectroscopy) and were compared with literature data. Alkaloids which had not previously been isolated and studied for cytotoxicity before and which were obtained in sufficient amounts were assayed for their cytotoxic activity on a panel of human cancer cell lines of different histotype. Above that, MRC-5 human fibroblasts were used as a control noncancerous cell line to determine the general toxicity of the tested compounds. The cytotoxicity of the tested alkaloids was evaluated using the WST-1 metabolic activity assay. The growth of all studied cancer cell lines was inhibited by pancracine (montanine-type alkaloid), with IC50 values which were in the range of 2.20 to 5.15 µM.
Open AccessAmaryllidaceae Alkaloids of Different Structural Types from Narcissus L. cv. Professor Einstein and Their Cytotoxic Activity
In this detailed phytochemical study of Narcissus cv. Professor Einstein, we isolated 23 previously known Amaryllidaceae alkaloids (1–23) of several structural types and one previously undescribed alkaloid, 7-oxonorpluviine. The chemical structures were identified by various spectroscopic methods (GC-MS, LC-MS, 1D, and 2D NMR spectroscopy) and were compared with literature data. Alkaloids which had not previously been isolated and studied for cytotoxicity before and which were obtained in sufficient amounts were assayed for their cytotoxic activity on a panel of human cancer cell lines of different histotype. Above that, MRC-5 human fibroblasts were used as a control noncancerous cell line to determine the general toxicity of the tested compounds. The cytotoxicity of the tested alkaloids was evaluated using the WST-1 metabolic activity assay. The growth of all studied cancer cell lines was inhibited by pancracine (montanine-type alkaloid), with IC50 values which were in the range of 2.20 to 5.15 µM.
- Open Access
- 10 November 2017
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 2 (11) , 7772-7776
Systematic Optimization of Liquid–Liquid Extraction for Isolation of Unidentified Components
We present a systematic approach for predicting the best solvents for selective extraction of components with unknown structure from complex mixtures (e.g., natural products)—a tool promising dramatic simplification of extraction process optimization. Its key advantage is that identification of the component(s) is unnecessary—prediction is based on a small set of experimental distribution coefficients (obtained using a combination of shake-flask extraction and chromatographic analysis) rather than structure-based descriptors. The methodology is suitable for the very common situations in practice where the desired compound needs to be separated from unknown impurities (i.e., selectively extracted from the mixture), as well as for large-scale and high-throughput work. The proof-of-concept methodology was developed and evaluated using an extensive set of experimental distribution data of lignin-related compounds obtained in this work.
- 10 November 2017
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 2 (11) , 7772-7776
Open AccessSystematic Optimization of Liquid–Liquid Extraction for Isolation of Unidentified Components
We present a systematic approach for predicting the best solvents for selective extraction of components with unknown structure from complex mixtures (e.g., natural products)—a tool promising dramatic simplification of extraction process optimization. Its key advantage is that identification of the component(s) is unnecessary—prediction is based on a small set of experimental distribution coefficients (obtained using a combination of shake-flask extraction and chromatographic analysis) rather than structure-based descriptors. The methodology is suitable for the very common situations in practice where the desired compound needs to be separated from unknown impurities (i.e., selectively extracted from the mixture), as well as for large-scale and high-throughput work. The proof-of-concept methodology was developed and evaluated using an extensive set of experimental distribution data of lignin-related compounds obtained in this work.
- 1 August 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1510, 1-12
Recent trends in determination of thiamine and its derivatives in clinical practice
- 1 August 2017
- Published by Elsevier in Journal of Chromatography A
- Vol. 1510, 1-12
Recent trends in determination of thiamine and its derivatives in clinical practice